--- title: The Scientist Speaks Podcast - The Reality of Regenerative Medicine description: After decades of research the potential of regenerative medicine becomes a life-saving reality. image: https://viewonline.the-scientist.com/hubfs/800x560-iStock-1065223632.jpg --- ![990x120](https://viewonline.the-scientist.com/hs-fs/hubfs/TS%20Podcasts/990x120.jpg?width=990&name=990x120.jpg "990x120") # The Reality of Regenerative Medicine An estimated 107,000 people in the United States are currently on the waiting list for organ transplantation. These patients face waiting times of 3-5 years or longer before receiving an organ. Even after receiving a donated organ, organ-transplant patients face a high risk of tissue rejection. Regenerative medicine promises the possibility of laboratory-grown organs, specially tailored to the biology and needs of individual patients, but how close is this technology to reality? In this month’s episode, we discuss the potential of regenerative medicine to replace damaged organs and tissues and cases where stem cell and regenerative medicine influence health today. Tiffany Garbutt from *The Scientist’s* Creative Services team spoke with Anthony Atala, the W. Boyce Professor and Chair of Urology and the G. Link Professor and Director of the Wake Forest Institute for Regenerative Medicine to learn more. **More on this topic** *The Scientist* Speaks is a podcast produced by *The Scientist’s* Creative Services team. Our podcast is by scientists and for scientists. Once a month, we bring you the stories behind news-worthy molecular biology research. This month's episode is sponsored by PHCbi.     Speaker ![Atala.jpg](https://viewonline.the-scientist.com/hubfs/Atala%20200x200.png "Atala.jpg") Anthony Atala, MD W. Boyce Professor and Chair of Urology G. Link Professor and Director Wake Forest Institute for Regenerative Medicine Wake Forest School of Medicine **Sponsored by** ![phcbi](https://viewonline.the-scientist.com/hs-fs/hubfs/LabManager/Images-Photos/PHCBI_LOGO.jpg?width=250&name=PHCBI_LOGO.jpg "phcbi") PHC Corporation of North America is a subsidiary of PHC Holdings Corporation, Tokyo, Japan, a global leader in development, design and manufacturing of laboratory equipment for the biopharmaceutical, life sciences, academic, healthcare and government markets. Biomedical product lines are marketed under the PHCbi brand. These products include the space saving and energy efficient VIP® ECO, TwinGuard® and VIP Series ultra-low temperature freezers, cryogenic and biomedical freezers, pharmacy and high-performance refrigerators, cell culture CO2 and multigas incubators, and Drosophila/Plant Growth Chambers. # Listen Now ### TS\_Podcast\_TSS\_August 2021\_The Reality of Regenerative Medicine Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this podcast. We may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows *The Scientist* to keep these podcasts free of charge for our readers. The Scientist c/o LabX Media Group 1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801 Toll Free: 888.788.0328 | Phone: 705.528.6888 Email: [privacy@the-scientist.com](mailto:privacy@the-scientist.com) [Privacy Policy](https://www.the-scientist.com/privacy-policy) © 1986-2022 [The Scientist](http://the-scientist.com/)   [![The Scientist Logo\_white](https://viewonline.the-scientist.com/hs-fs/hubfs/The%20Scientist%20Logo_white.png?width=702&name=The%20Scientist%20Logo_white.png "The Scientist Logo_white")](https://www.the-scientist.com) The Scientist needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our [Privacy Policy.](https://www.the-scientist.com/privacy-policy)